Halt Medical Closes First $20M Tranche of $50M Financing
Halt Medical, Inc., a Livermore, CA-based medical device company focused on women’s health, has closed the first $20m tranche of a $50m debt and equity financing.
The round was led by American Capital Strategies (ACAS).
Founded in 2004 and led by CEO Jeff Cohen, and President & COO Russ DeLonzor, the company has developed a procedure and related equipment for treating uterine fibroids, the Halt Global Fibroid Ablation (GFA) System.
Halt Medical, which will close on another $10m during this first quarter of 2012 with the option for an additional $20m, intends the funds to launch its GFA System in major markets around the world.